Utility of Indocyanine Green Fluorescence in Endoscopic Sinonasal and Skull Base Surgery (NIRFICG)
Chronic Sinusitis, Tumor of Nasal Sinus, Posterior Epistaxis
About this trial
This is an interventional other trial for Chronic Sinusitis focused on measuring Indocyanine Green, Endoscopic Sinus Surgery, Skullbase Surgery, Sinonasal tumors
Eligibility Criteria
Inclusion Criteria:
- All patients undergoing skull base surgery with nasoseptal flap reconstruction.
- All patients undergoing endoscopic sinonasal surgery for benign and malignant tumor removal.
- All patients undergoing endoscopic sinus surgery for chronic rhinosinusitis (CRS) with or without polyposis.
- All patients undergoing surgical intervention for posterior epistaxis.
Exclusion Criteria:
- Patients less than 18 years of age
- Patients whom are currently pregnant
- Patients with allergies to sodium iodide or shellfish
- Patients with previous anaphylactic reaction to ICG
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm 4
Other
Other
Other
Other
Sinus Tumor Resection
Skull Base Surgery
Endoscopic Sinus Surgery
Epistaxis Management
Those who are undergoing endoscopic sinonasal surgery for benign and malignant tumor removal.
Those who are receiving Endoscopic Skull Base Surgery (ESBS) for minimally-invasive access for removal of skull base tumors, most commonly for ones of pituitary origin.
Individuals with chronic rhinosinusitis (CRS) with or without polyposis that are to have endoscopic sinus surgery, a minimally invasive procedure to open the sinuses.
Those who have severe nose bleeds and requires going into the operating room for management.